References
- Greipp PR, Raymond NM, Kyle RA, . Multiple myeloma: significance of plasmablastic subtype in morphological classification. Blood 1985;65:305–310.
- Bellamy WT, Richer L, Frutiger Y, TM. Expression of vascular endothelial growth factor and its receptors in hematopoietic malignancies. Cancer Res 1999;59:728–733.
- Masood R, Cai J, Zheng T, . Vascular endothelial growth factor (VEGF) is an autocrine growth factor for VEGF receptor-positive tumors. Blood 2001;98:1904–1913.
- Dankbar B, Padró T, Leo R, . Vascular endothelial growth factor and interleukin-6 in paracrine tumor-stromal cell interactions in multiple myeloma. Blood 2000;95:2630–2636
- Soker S, Kaefer M, Johnson M, . Vascular endothelial growth factor-mediated autocrine stimulation of prostate tumor cells coincides with progression to a malignant phenotype. Am J Pathol 2001;159:651–659.
- Chan AS, Leung SY, Wong MP, . Expression of vascular endothelial growth factor and its receptors in the anaplastic progression of astrocytoma, oligodendroglioma, and ependymoma. Am J Surg Pathol 1998;22:816–826.
- Brown LF, Berse B, Jackman RW, . Expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in breast cancer. Hum Pathol 1995;26:86–91.
- Hiratsuka S, Maru Y, Okada A, . Involvement of Flt-1 tyrosine kinase (vascular endothelial growth factor receptor-1) I pathological angiogenesis. Cancer Res 2001;61:1207–1213.
- Herold-Mende C, Steiner HH, Andl T, . Expression and functional significance of vascular endothelial growth factor receptors in human tumor cells. Lab Invest 1999;79:1573–1582.
- Kumar S, Witzig TE, Timm M, . Expression of VEGF and its receptors by myeloma cells. Leukemia 2003;17:2025–2031.
- Vacca A, Ria R, Ribatti D, . A paracrine loop in the vascular endothelial growth factor pathway triggers tumor angiogenesis and growth in multiple myeloma. Haematologica 2003;88:176–185
- Urashima M, Chauhan D, Uchiyama H, . CD40 ligand triggered interleukin-6 secretion in multiple myeloma. Blood 1995;85:1903–1912
- Carter A, Merchav S, Silvian-Draxler I, . The role of interleukin-1 and tumor necrosis factor-alpha in human multiple myeloma. Br J Haematol 1990;74:424–431.
- Wu Y, Zhou BP. TNF-alpha/NF-kappaB/Snail pathway in cancer cell migration and invasion. Br J Cancer 2010;102:639–644.
- Jourdan M, Tarte K, Legouffe E, . Tumor necrosis factor is a survival and proliferation factor for human myeloma cells. Eur Cytokine Netw 1999;10:65–70.